An injectable excipient prevents anti-polyethylene glycol antibody-mediated hypersensitivity

Allergy. 2021 Sep;76(9):2902-2904. doi: 10.1111/all.14901. Epub 2021 May 29.

Authors

Yiwei Liu¹, Colton A Smith¹, Monique Payton², David Jenkins³, Laura J Janke⁴, Mary V Relling¹

Affiliations

¹ Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
² Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
³ GMP, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
⁴ Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

No abstract available

Keywords: COVID-19 vaccine; allergy; hapten inhibition; hypersensitivity reaction; polyethylene glycol.

Publication types

Letter

MeSH terms

Anaphylaxis*
Excipients*
Humans
Polyethylene Glycols

Substances

Excipients
Polyethylene Glycols

Grants and funding